Influenza A viruses (lAV) and Ebola viruses (EBOV) are negafive-sense RNA viruses that cause human infecfions associated with respiratory disease or hemorrhagic fever, respectively. Both viruses have small genomes, encoding only 11-12 (lAV) or 8 (EBOV) known viral proteins;however, the idenfification of novel proteins in recent years suggests that these viruses may encode additional uncharacterized genes that are transcribed or transcribed/translated, via non-conventional strategies. We hypothesize that these genes and their products likely contribute to the viral life cycle. Therefore, the goal of research project 2 (RP 2) is to identify and determine the functions of uncharacterized lAV and EBOV genes. In Aini 1, we will experimentally prove that hypothetical genes can be expressed from the genomes of lAV and EBOV at the protein level. For all uncharacterized gene categories;1) proven hypothefical gene candidates, 2) unknown open reading frame candidates (i.e., viral proteins already known to be expressed but not yet functionally characterized), and 3) noncoding viral RNA candidates, we will assess the biochemical function of these uncharacterized gene candidates, including using apoptosis assays in our laboratory. Additional biochemical assays will be perfonned in RP 1 - Baric to examine the role of uncharacterized genes in interferon and tolllike receptor signaling and in RP 3 - Damania to examine the role of uncharacterized genes in inflammasome and p53 signaling. Collecfively, all three RPs will contribute various assays to determine the biochemical funcfion of the uncharacterized genes in this proposal. By using reverse genefics techniques developed in our laboratory for lAV and EBOV, we will generate mutant viruses that no longer encode the uncharacterized gene product. We will then compare the growth kinetics and host responses to infection of wild-type virus and mutant viruses in cell culture (Aim 2) and in a mouse model (Aim 3). In addition, we will perform confocal microscopy imagining (Aim 2) to determine the subcellular localization of the potentially novel lAV and EBOV gene products, and also of potentially novel SARS coronavirus (RP 1) and human herpesviruses-8 (RP 3) gene products. Such microscopy studies will aid in determining the function of these

Public Health Relevance

Influenza A virus (lAV) and Ebola virus (EBOV) are classified as Category C and Category A priority agents, respectively, by the Nafional Institute of Allergy and Infectious Diseases (NIAID). Despite encoding only 11- 12 (lAV) or8 (EBOV) known viral proteins, both vinjses can cause severe, somefimes fatal infections in humans. Here, we seek to idenfify and determine the function of uncharacterized lAV and EBOV genes in an effort to identify new viral targets for therapeutic development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI107810-02
Application #
8687585
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
City
Chapel Hill
State
NC
Country
United States
Zip Code
Schifano, Jason M; Corcoran, Kathleen; Kelkar, Hemant et al. (2016) Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus. J Virol :
Baric, Ralph S; Crosson, Sean; Damania, Blossom et al. (2016) Next-Generation High-Throughput Functional Annotation of Microbial Genomes. MBio 7:
Ma, Zhe; Damania, Blossom (2016) The cGAS-STING Defense Pathway and Its Counteraction by Viruses. Cell Host Microbe 19:150-8
Bhatt, Aadra Prashant; Wong, Jason P; Weinberg, Marc S et al. (2016) A viral kinase mimics S6 kinase to enhance cell proliferation. Proc Natl Acad Sci U S A 113:7876-81
Dittmer, Dirk P (2016) Zika vaccine: Clinical trial and error? Science 353:1375
Zhang, Zhigang; Chen, Wuguo; Sanders, Marcia K et al. (2016) The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication. J Virol 90:7657-66
Menachery, Vineet D; Yount Jr, Boyd L; Sims, Amy C et al. (2016) SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A 113:3048-53
Damania, Blossom (2016) A Virological Perspective on Cancer. PLoS Pathog 12:e1005326
Thornbrough, Joshua M; Jha, Babal K; Yount, Boyd et al. (2016) Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation. MBio 7:e00258
Giffin, Louise; West, John A; Damania, Blossom (2015) Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration. MBio 6:e01499-15

Showing the most recent 10 out of 31 publications